Author

Julie A. E. Irving

Newcastle UniversityORCID 0000-0002-4497-7089Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Approach:statistical model· 1

Frequent Co-Authors

Alistair A. PolliD· 1 shared Andreas E. KulozikiD· 1 shared Beat C. BornhauseriD· 1 shared Frederik W. van DelftiD· 1 shared Jean‐Pierre BourquiniD· 1 shared Kerstin Katharina RauwolfiD· 1 shared Yuzhe ShiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alistair A. PollORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Phospho 394Y LCK flow-cytometry readout predicts dasatinib sensitivity in paediatric T-cell acute lymphoblastic leukaemia

Alistair A. Poll, Yuzhe Shi, Kerstin Katharina Rauwolf, Beat C. Bornhauser, Andreas E. Kulozik, Jean‐Pierre Bourquin, Julie A. E. Irving, Frederik W. van Delft

The paper identifies phospho-LCK (pY394) as a biomarker for dasatinib sensitivity in paediatric T-ALL using flow-cytometry, showing strong correlation with drug response.

bioRxiv · Nov 4, 2025 · PreprintCancer Biology